Zylet FDA Approval History
FDA Approved: Yes (First approved December 14, 2004)
Brand name: Zylet
Generic name: loteprednol and tobramycin
Dosage form: Ophthalmic Suspension
Company: Bausch & Lomb Inc.
Treatment for: Uveitis, Iritis, Conjunctivitis, Bacterial, Keratitis, Cyclitis
Zylet (loteprednol etabonate and tobramycin ophthalmic suspension) a topical anti-inflammatory corticosteroid and antibiotic combination for use in the treatment of inflammatory ocular conditions.
Development timeline for Zylet
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.